Agonists and antagonists of the GIP receptor influence body weight ... At the same time, GLP-1 inhibits the release of glucagon, a hormone that increases blood sugar levels. In addition, GLP ...

At the same time, GLP-1 inhibits the release of glucagon, a hormone that increases blood ... GLP-1 reduces the feeling of hunger via specific satiety centers in the brain. GIP also appears to ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

Note – this is an early press release from the European Congress ... much more aware of knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and tirzepatide).